Get the Stockscreener App
2.56
1.99%
0.05
After Hours:
2.54
-0.02
-0.78%
Bioharvest Sciences Inc stock is traded at $2.56, with a volume of 113.27K.
It is up +1.99% in the last 24 hours and down -11.72% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$2.51
Open:
$2.54
24h Volume:
113.27K
Relative Volume:
3.05
Market Cap:
$58.03M
Revenue:
$35.16M
Net Income/Loss:
$-11.44M
P/E Ratio:
-4.2946
EPS:
-0.5961
Net Cash Flow:
$-15.44M
1W Performance:
+18.52%
1M Performance:
-11.72%
6M Performance:
-46.56%
1Y Performance:
-68.39%
1-Day Range:
$2.37
$2.805
1-Week Range:
$2.12
$2.9899
52-Week Range:
$1.82
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs JBS, KHC, GIS, MKC, HRL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.56 | 46.02M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
14.23 | 44.57B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
25.32 | 31.09B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
36.89 | 19.54B | 18.42B | -85.30M | 1.63B | -0.1894 |
MKC
Mccormick Co Inc
|
52.96 | 13.61B | 7.39B | 1.63B | 1.02B | 6.0085 |
HRL
Hormel Foods Corp
|
25.02 | 14.34B | 12.22B | 466.64M | 692.94M | 0.8477 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences to Unveil Q2 2026 Financial Results on August 11, 2026 - Kalkine Media
BioHarvest CEO to discuss first 100 days and 2026 growth plan - Stock Titan
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioharvest Sciences Inc (BHST) Balance Sheet - TradingKey
Bioharvest Sciences Inc (BHST) Cash Flow - TradingKey
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioHarvest Sciences, Inc. Revenue Breakdown – LSX:A40C6G - TradingView
BioHarvest Sciences Inc. Revenue Breakdown – NASDAQ:BHST - TradingView
Bioharvest Sciences Inc (BHST) Income Statement - TradingKey
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc (BHST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BHST|Bioharvest Sciences Inc|Price:1.920|Chg%:-0.080 - TradingKey
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BHST|Bioharvest Sciences Inc|Price:2.050|Chg%:+0.130 - TradingKey
Bioharvest Sciences Inc (BHST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Institutional Confidence - TradingKey
Enterprise value to revenue forward of BioHarvest Sciences, Inc. – MUN:8MV0 - TradingView
Bioharvest Sciences Inc (BHST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
Market Sentiment Around Loss-Making BioHarvest Sciences Inc. (NASDAQ:BHST) - webull.com
Price to earnings forward of BioHarvest Sciences, Inc. – DUS:8MV0 - TradingView
BioHarvest Sciences Inc. (BHST) Slips 4% as Stock Tests Key Support LevelsOversold Bounce Ideas - dars.gov.et
BioHarvest Sciences Inc. (BHST) Declines 2.81% as Stock Tests Support Near $2.63Blue Chip Entry Points - dars.gov.et
BioHarvest Sciences (BHST) secures $1.4M Israel AI R&D funding - Stock Titan
BioHarvest Sciences (NASDAQ: BHST) secures $1.4M AI plant-cell research grant - Stock Titan
Market movers: Aehr Test Systems, BioHarvest Sciences, Dell, Century Lithium... - Proactive financial news
BioHarvest receives $1.4M grant for AI research platform By Investing.com - Investing.com Nigeria
BioHarvest Sciences secures $1.4M grant to boos... - Pluang
BioHarvest lands $1.4M grant for AI-driven plant science - Yahoo Finance
BioHarvest receives $1.4M grant for AI research platform - Investing.com
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis - TMX Newsfile
BioHarvest Sciences to Participate in the 'Health, Wellness & Longevity' Virtual Conference Presented by Maxim Group LLC - marketscreener.com
BioHarvest Sciences : to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC - marketscreener.com
BioHarvest CEO to speak at Maxim Health, Wellness & Longevity Conference - Proactive financial news
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC - marketscreener.com
BioHarvest Sciences Inc. Q1 2025 Earnings: Wider Loss per Share Misses Analyst ExpectationsCapex Guidance - dars.gov.et
BHSTBioHarvest Sciences Inc Latest SEC Filings - Finviz
BioHarvest Sciences (BHST) Rebounds 1.75% as Buyers Defend Key Support ZoneNAAIM Leverage - dars.gov.et
BioHarvest Sciences Inc. (BHST) Extends Gains, Tests Key Resistance at $3.06Overnight Profile - dars.gov.et
BioHarvest Sciences, Inc. Actuals & Estimates (MUN:8MV0) - TradingView
BioHarvest Sciences Inc. (BHST) reports Q1 loss, beats revenue estimates - MSN
BioHarvest Sciences, Inc. Actuals & Estimates (NASDAQ:BHST) - TradingView
8MV0 Forecast — Price Target — Prediction for 2027 - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (DUS:8MV0) - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (LS:A40C6G) - TradingView
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Miss Signals Continued Investment in GrowthEarnings Quality Score - dars.gov.et
BioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International Convention - The Globe and Mail
BioHarvest Sciences (BHST) to showcase Botanical Synthesis at 2026 BIO Convention - Stock Titan
BioHarvest brings its plant-based tech to BIO International in San Diego - Stock Titan
BioHarvest Sciences to present botanical synthesis platform at BIO International Convention - Proactive financial news
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):